"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,US,A1,US 2021/0246019 A1,021-453-873-744-097,2021-08-12,2021,US 202117170785 A,2021-02-08,US 202117170785 A;;US 202062971593 P;;US 202063071588 P,2020-02-07,PEPTIDE/LIPID-ASSOCIATED NUCLEIC ACIDS (PLANA) FOR NUCLEIC ACID DELIVERY,"Disclosed are compositions and methods for delivering nucleic acids and other substances into living cells. The compositions constitute a delivery system comprising a peptide component with hydrophobic and positively-charged portions, and a lipid component. Any nucleic acid can be delivered including siRNA, mRNA, and DNA. The delivered nucleic acid can have therapeutic or prophylactic effect.",CHAPMAN UNIV,ALIABADI HAMIDREZA MONTAZERI;;PARANG KEYKAVOUS;;HALL RYLEY;;ALASMARI ABDULAZIZ,CHAPMAN UNIVERSITY (2020-09-14),https://lens.org/021-453-873-744-097,Patent Application,yes,0,0,1,1,4,A61K47/6455;;A61K47/6929;;B82Y5/00;;A61K47/543;;A61K47/18;;A61K47/26;;A61K47/6929;;A61K47/6455,B82Y5/00;;A61K47/18;;A61K47/26;;A61K47/54;;A61K47/69,,1,1,113-278-530-633-90X,23727262;;10.1016/j.biomaterials.2013.04.060,"Resnier et al., Biomaterials, 2013, 34: 6429-6443.",PENDING
2,WO,A1,WO 2023/014909 A1,149-671-255-200-137,2023-02-09,2023,US 2022/0039469 W,2022-08-04,US 202163229149 P,2021-08-04,AMPHIPHILIC PEPTIDES FOR NUCLEIC ACID AND PROTEIN DELIVERY,"Disclosed are transfecting agents for delivery of nucleic acids (e.g., DNA, plasmids, oligos, small interfering RNAs [siRNA], small hairpin RNA [shRNA], microRNAs [miRNA], Clustered Regularly Interspaced Short Palindromic Repeats [CRISPR]) or proteins (phosphoproteins, enzymes, antibodies, vaccines) using a peptide-based, pegylated peptide-based, a peptide attached to a lipophilic moiety (lipidated peptides), or lipophilic pegylated peptides to living cells.",AJK BIOPHARMACEUTICAL LLC,PARANG KEYKAVOUS;;ALIABADI HAMIDREZA MONTAZERI;;LOHAN SANDEEP;;MANDAL DINDYAL;;TIWARI RAKESH;;MOHAMMED EMAN;;HALL RYLEY,,https://lens.org/149-671-255-200-137,Patent Application,yes,2,0,1,1,0,A61K47/60;;A61K47/6455;;C12N15/87;;C07K7/06;;C07K7/08;;C07K7/56;;C07K7/02,A61K51/10;;A61K39/395,,0,0,,,,PENDING
3,US,A1,US 2022/0265839 A1,026-461-073-469-674,2022-08-25,2022,US 202217673519 A,2022-02-16,US 202217673519 A;;US 202163149771 P,2021-02-16,TARGETED PEPTIDE-DRUG CONJUGATES,Provided herein are drug delivery systems comprising a peptide targeting agent and a pharmaceutical agent for delivery of chemotherapeutic agents. Also provided are methods of treating cancer comprising administration of the drug delivery system disclosed herein.,CHAPMAN UNIV,MOZAFFARI SAGHAR;;SALEHI DAVID;;MAHDIPOOR PARVIN;;TIWARI RAKESH;;ALIABADI HAMIDREZA MONTAZERI;;PARANG KEYKAVOUS;;ZOGHEBI KHALID,,https://lens.org/026-461-073-469-674,Patent Application,yes,0,0,1,1,0,A61K31/704;;A61P35/00;;A61K47/64;;A61K47/64;;A61P35/00;;A61K31/704,A61K47/64;;A61K31/704;;A61P35/00,,1,1,007-333-362-771-559,33496597;;10.1021/acs.molpharmaceut.0c00969,"Hall R, Alasmari A, Mozaffari S, Mahdipoor P, Parang K, Montazeri Aliabadi H. Peptide/Lipid-Associated Nucleic Acids (PLANAs) as a Multicomponent siRNA Delivery System. Mol Pharm. 2021 Mar 1;18(3):986-1002. doi: 10.1021/acs.molpharmaceut.0c00969. Epub 2021 Jan 26. PMID: 33496597. (Year: 2021)",PENDING
4,WO,A2,WO 2021/134023 A2,105-933-506-793-987,2021-07-01,2021,US 2020/0067029 W,2020-12-24,US 201962953365 P;;US 202063013843 P,2019-12-24,COMPOSITIONS AND METHODS FOR NUCLEIC ACID DELIVERY,"Peptide-based systems containing hydrophobic amino acids (e.g., tryptophan), charged amino acids (e.g., arginine), and/or sulfur-containing amino acids (e.g., cysteine), which can be used either alone or in combination with nanoparticles (e.g., gold or silver nanoparticles) for siRNA delivery into living cells are disclosed.",AJK PHARMACEUTICAL LLC;;PARANG KEYKAVOUS;;MONTAZERI ALIABADI HAMIDREZA;;MANDAL DINDYAL;;MOHAMMED EMAN;;MOZAFFARI SAGHAR;;LOHAN SANDEEP;;TIWARI RAKESH;;HALL RYLEY,PARANG KEYKAVOUS;;MONTAZERI ALIABADI HAMIDREZA;;MANDAL DINDYAL;;MOHAMMED EMAN;;MOZAFFARI SAGHAR;;LOHAN SANDEEP;;TIWARI RAKESH;;HALL RYLEY,,https://lens.org/105-933-506-793-987,Patent Application,yes,0,2,5,5,102,A61K47/6455;;A61K47/60;;A61K47/62;;A61K47/6923;;A61K47/6929;;C12N15/87;;C12N15/111;;C12N2320/32;;A61K8/64;;A61Q19/00;;A61Q5/02;;C07K7/06;;C07K7/08;;C07K7/64;;C12N2310/20;;A61K47/6455;;A61K47/6929;;A61K47/6923;;A61K47/60;;A61P35/00;;A61K8/606;;A61K8/64;;A61K48/0033;;A61Q19/00;;C07K7/06;;C07K7/08;;C07K7/64;;C12N15/11;;C12N15/113;;C12N2310/14;;C12N2310/3513;;C12N2320/32,A61K41/00,,0,0,,,,PENDING
5,WO,A2,WO 2021/134026 A2,055-611-885-923-222,2021-07-01,2021,US 2020/0067036 W,2020-12-24,US 201962953365 P;;US 202063013843 P,2019-12-24,COMPOSITIONS AND METHODS FOR NUCLEIC ACID DELIVERY,"Peptide-based systems containing hydrophobic amino acids (e.g., tryptophan), charged amino acids (e.g., arginine), and/or sulfur-containing amino acids (e.g., cysteine), which can be used either alone or in combination with nanoparticles (e.g., gold or silver nanoparticles) for siRNA delivery into living cells are disclosed.",AJK PHARMACEUTICAL LLC;;PARANG KEYKAVOUS;;MONTAZERI ALIABADI HAMIDREZA;;MANDAL DINDYAL;;MOHAMMED EMAN;;MOZAFFARI SAGHAR;;LOHAN SANDEEP;;TIWARI RAKESH;;HALL RYLEY,PARANG KEYKAVOUS;;MONTAZERI ALIABADI HAMIDREZA;;MANDAL DINDYAL;;MOHAMMED EMAN;;MOZAFFARI SAGHAR;;LOHAN SANDEEP;;TIWARI RAKESH;;HALL RYLEY,,https://lens.org/055-611-885-923-222,Patent Application,yes,0,1,5,5,102,A61K47/6455;;A61K47/60;;A61K47/62;;A61K47/6923;;A61K47/6929;;C12N15/87;;C12N15/111;;C12N2320/32;;A61K8/64;;A61Q19/00;;A61Q5/02;;C07K7/06;;C07K7/08;;C07K7/64;;C12N2310/20;;A61K47/6455;;A61K47/6929;;A61K47/6923;;A61K47/60;;A61P35/00;;A61K8/606;;A61K8/64;;A61K48/0033;;A61Q19/00;;C07K7/06;;C07K7/08;;C07K7/64;;C12N15/11;;C12N15/113;;C12N2310/14;;C12N2310/3513;;C12N2320/32,A61K47/32,,0,0,,,,PENDING
6,US,A1,US 2023/0000999 A1,039-308-445-269-528,2023-01-05,2023,US 202017788954 A,2020-12-24,US 202017788954 A;;US 202063013843 P;;US 201962953365 P;;US 2020/0067036 W,2019-12-24,COMPOSITIONS AND METHODS FOR NUCLEIC ACID DELIVERY,"Peptide-based systems containing hydrophobic amino acids (e.g., tryptophan), charged amino acids (e.g., arginine), and/or sulfur-containing amino acids (e.g., cysteine), which can be used either alone or in combination with nanoparticles (e.g., gold or silver nanoparticles) for siRNA delivery into living cells are disclosed.",PARANG KEYKAVOUS;;MONTAZERI ALIABADI HAMIDREZA;;MANDAL DINDYAL;;MOHAMMED EMAN;;MOZAFFARI SAGHAR;;LOHAN SANDEEP;;TIWARI RAKESH;;HALL RYLEY;;AJK BIOPHARMACEUTICAL LLC,PARANG KEYKAVOUS;;MONTAZERI ALIABADI HAMIDREZA;;MANDAL DINDYAL;;MOHAMMED EMAN;;MOZAFFARI SAGHAR;;LOHAN SANDEEP;;TIWARI RAKESH;;HALL RYLEY,,https://lens.org/039-308-445-269-528,Patent Application,yes,0,0,5,5,102,A61K47/6455;;A61K47/60;;A61K47/62;;A61K47/6923;;A61K47/6929;;C12N15/87;;C12N15/111;;C12N2320/32;;A61K8/64;;A61Q19/00;;A61Q5/02;;C07K7/06;;C07K7/08;;C07K7/64;;C12N2310/20;;A61K47/6455;;A61K47/6929;;A61K47/6923;;A61K47/60;;A61P35/00;;A61K8/606;;A61K8/64;;A61K48/0033;;A61Q19/00;;C07K7/06;;C07K7/08;;C07K7/64;;C12N15/11;;C12N15/113;;C12N2310/14;;C12N2310/3513;;C12N2320/32,A61K47/64;;A61K8/60;;A61K8/64;;A61K47/60;;A61K47/69;;A61K48/00;;A61P35/00;;A61Q19/00;;C07K7/06;;C07K7/08;;C07K7/64;;C12N15/11;;C12N15/113,,0,0,,,,PENDING
7,WO,A3,WO 2021/134023 A3,116-221-550-600-269,2021-08-05,2021,US 2020/0067029 W,2020-12-24,US 201962953365 P;;US 202063013843 P,2019-12-24,COMPOSITIONS AND METHODS FOR NUCLEIC ACID DELIVERY,"Peptide-based systems containing hydrophobic amino acids (e.g., tryptophan), charged amino acids (e.g., arginine), and/or sulfur-containing amino acids (e.g., cysteine), which can be used either alone or in combination with nanoparticles (e.g., gold or silver nanoparticles) for siRNA delivery into living cells are disclosed.",AJK PHARMACEUTICAL LLC;;PARANG KEYKAVOUS;;MONTAZERI ALIABADI HAMIDREZA;;MANDAL DINDYAL;;MOHAMMED EMAN;;MOZAFFARI SAGHAR;;LOHAN SANDEEP;;TIWARI RAKESH;;HALL RYLEY,PARANG KEYKAVOUS;;MONTAZERI ALIABADI HAMIDREZA;;MANDAL DINDYAL;;MOHAMMED EMAN;;MOZAFFARI SAGHAR;;LOHAN SANDEEP;;TIWARI RAKESH;;HALL RYLEY,,https://lens.org/116-221-550-600-269,Search Report,yes,3,0,5,5,102,A61K47/6455;;A61K47/60;;A61K47/62;;A61K47/6923;;A61K47/6929;;C12N15/87;;C12N15/111;;C12N2320/32;;A61K8/64;;A61Q19/00;;A61Q5/02;;C07K7/06;;C07K7/08;;C07K7/64;;C12N2310/20;;A61K47/6455;;A61K47/6929;;A61K47/6923;;A61K47/60;;A61P35/00;;A61K8/606;;A61K8/64;;A61K48/0033;;A61Q19/00;;C07K7/06;;C07K7/08;;C07K7/64;;C12N15/11;;C12N15/113;;C12N2310/14;;C12N2310/3513;;C12N2320/32,A61K38/12;;A61K8/64,,0,0,,,,PENDING
8,WO,A3,WO 2021/134026 A3,118-609-670-035-560,2021-11-18,2021,US 2020/0067036 W,2020-12-24,US 201962953365 P;;US 202063013843 P,2019-12-24,COMPOSITIONS AND METHODS FOR NUCLEIC ACID DELIVERY,"Peptide-based systems containing hydrophobic amino acids (e.g., tryptophan), charged amino acids (e.g., arginine), and/or sulfur-containing amino acids (e.g., cysteine), which can be used either alone or in combination with nanoparticles (e.g., gold or silver nanoparticles) for siRNA delivery into living cells are disclosed.",AJK PHARMACEUTICAL LLC;;PARANG KEYKAVOUS;;MONTAZERI ALIABADI HAMIDREZA;;MANDAL DINDYAL;;MOHAMMED EMAN;;MOZAFFARI SAGHAR;;LOHAN SANDEEP;;TIWARI RAKESH;;HALL RYLEY,PARANG KEYKAVOUS;;MONTAZERI ALIABADI HAMIDREZA;;MANDAL DINDYAL;;MOHAMMED EMAN;;MOZAFFARI SAGHAR;;LOHAN SANDEEP;;TIWARI RAKESH;;HALL RYLEY,,https://lens.org/118-609-670-035-560,Search Report,yes,2,0,5,5,102,A61K47/6455;;A61K47/60;;A61K47/62;;A61K47/6923;;A61K47/6929;;C12N15/87;;C12N15/111;;C12N2320/32;;A61K8/64;;A61Q19/00;;A61Q5/02;;C07K7/06;;C07K7/08;;C07K7/64;;C12N2310/20;;A61K47/6455;;A61K47/6929;;A61K47/6923;;A61K47/60;;A61P35/00;;A61K8/606;;A61K8/64;;A61K48/0033;;A61Q19/00;;C07K7/06;;C07K7/08;;C07K7/64;;C12N15/11;;C12N15/113;;C12N2310/14;;C12N2310/3513;;C12N2320/32,C07K7/64;;A61K47/64;;C07K7/06;;C07K7/08,,0,0,,,,PENDING
